The general technique of AAC preparation is well established, and pre-clinical and clinical verification of lower toxicity, higher anticancer activity, and improved stability of AAC recognizing multiple myeloma markers and delivering specific autoantigens may represent a significant trend in the upcoming years.
1
—
—